Koka Indonesia Tbk. vs Merck Tbk. — how do they compare? Koka Indonesia Tbk. trades at Rp171 (market cap 489.29B, 13.04M 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 3.5× Koka Indonesia Tbk.'s market cap, and Koka Indonesia Tbk. is more actively traded (13.04M versus 37.6K). Which is the better fit depends on your goals.
| KOKA | MERK | |
|---|---|---|
Market Cap | 489.29B | 1.7T |
Volume | 13.04M | 37.6K |
Lot | 130.35K | 376 |
Turnover | 2.26B | 144.47M |
Average Price | 173.32 | 3,842.23 |
Value | 2.26B | 144.47M |
Indicative Equilibrium Price | 171 | 3,840 |
Indicative Equilibrium Volume | 12.44K | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Koka Indonesia Tbk (the Entity) was established in Jakarta, based on Notarial Deed of Innovani Damanik, S.H., M.Kn., No. 45, dated June 21, 2011. The Entity started commercial operations in 2012.
Read more on KOKA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →